Growth Metrics

Apyx Medical (APYX) Return on Invested Capital (2016 - 2025)

Apyx Medical's Return on Invested Capital history spans 15 years, with the latest figure at 0.23% for Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 15.0% year-over-year to 0.23%; the TTM value through Dec 2025 reached 0.23%, up 15.0%, while the annual FY2025 figure was 0.2%, 13.0% up from the prior year.
  • Return on Invested Capital reached 0.23% in Q4 2025 per APYX's latest filing, down from 0.22% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.22% in Q3 2025 to a low of 0.6% in Q4 2022.
  • Average Return on Invested Capital over 5 years is 0.34%, with a median of 0.31% recorded in 2024.
  • Peak YoY movement for Return on Invested Capital: crashed -32bps in 2022, then soared 31bps in 2023.
  • A 5-year view of Return on Invested Capital shows it stood at 0.27% in 2021, then plummeted by -119bps to 0.6% in 2022, then surged by 52bps to 0.29% in 2023, then plummeted by -33bps to 0.38% in 2024, then skyrocketed by 40bps to 0.23% in 2025.
  • Per Business Quant, the three most recent readings for APYX's Return on Invested Capital are 0.23% (Q4 2025), 0.22% (Q3 2025), and 0.27% (Q2 2025).